Cargando…
Liquid Biopsy and Therapeutic Targets: Present and Future Issues in Thoracic Oncology
The practice of liquid biopsy (LB) has revolutionized the care of patients with metastatic lung cancer. Many oncologists now use this approach in daily practice, applying precise procedures for the detection of activating or resistance mutations in EGFR. These tests are performed with plasma DNA and...
Autor principal: | Hofman, Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5704172/ https://www.ncbi.nlm.nih.gov/pubmed/29125548 http://dx.doi.org/10.3390/cancers9110154 |
Ejemplares similares
-
Role of liquid biopsy for thoracic cancers immunotherapy
por: Di Liello, Raimondo, et al.
Publicado: (2020) -
Clinical Perspective and Translational Oncology of Liquid Biopsy
por: Fernández-Lázaro, Diego, et al.
Publicado: (2020) -
Detecting Resistance to Therapeutic ALK Inhibitors in Tumor Tissue and Liquid Biopsy Markers: An Update to a Clinical Routine Practice
por: Hofman, Paul
Publicado: (2021) -
Radiomics and liquid biopsy in oncology: the holons of systems medicine
por: Neri, Emanuele, et al.
Publicado: (2018) -
Transcending Blood—Opportunities for Alternate Liquid Biopsies in Oncology
por: Werner, Bonnita, et al.
Publicado: (2022)